Form 8-K - Current report:
SEC Accession No. 0001437749-21-028538
Filing Date
2021-12-14
Accepted
2021-12-14 16:05:18
Documents
13
Period of Report
2021-12-13
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20211214_8k.htm   iXBRL 8-K 28119
  Complete submission text file 0001437749-21-028538.txt   161106

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA stab-20211213.xsd EX-101.SCH 3594
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20211213_def.xml EX-101.DEF 11425
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20211213_lab.xml EX-101.LAB 15311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20211213_pre.xml EX-101.PRE 11585
6 EXTRACTED XBRL INSTANCE DOCUMENT cbli20211214_8k_htm.xml XML 2569
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 211491023
SIC: 2834 Pharmaceutical Preparations